Clinical correlation of the venom-specific IgG antibody level during maintenance venom immunotherapy

The Journal of Allergy and Clinical Immunology

Volumn 90, Issue 3 PART 1, 1992, Pages 386-393

  Golden, David B K ^a   Lawrence, Ira D ^a   Hamilton, Robert H ^a   Kagey Sobotka, Anne ^a   Valentine, Martin D ^a   Lichtenstein, Lawrence M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

anaphylaxis; Hymenoptera; IgG antibodies; immunotherapy; Insect sting allergy; venom

Indexed keywords

ADRENALIN; ALLPYRAL; BEE VENOM; IMMUNOGLOBULIN G ANTIBODY; INSECT VENOM;

ADULT; AGED; ANAPHYLAXIS; ANTIBODY BLOOD LEVEL; ARTICLE; FLUSHING; HUMAN; HYMENOPTERA; HYPOTENSION; IMMUNOTHERAPY; INSECT ALLERGY; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PRURITUS; URTICARIA; VERTIGO;

ADULT; BEE VENOMS; DESENSITIZATION, IMMUNOLOGIC; HUMAN; IMMUNOGLOBULIN G; INSECT BITES AND STINGS; MIDDLE AGE; RISK; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; WASP VENOMS;

EID: 0026713346     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(05)80019-3     Document Type: Article

References (38)

1. Serological evidence of immunity with co-existing sensitization in a type of human allergy (hay fever)
2. Immunological studies of pollenosis. IV. The relationship between thermostable antibody in the circulation and clinical immunity
3. A quantitative in vitro study of the chromatographic distribution and immunoglobulin characteristics of human blocking antibody
4. A single year of immunotherapy of ragweed hay fever: immunologic and clinical studies
5. Effect of immunotherapy on immunoglobulin E and immunoglobulin G antibodies to ragweed antigens: a six-year prospective study
6. The effect of immunotherapy on humoral and cellular response in ragweed hay fever
7. Measurement of IgG-blocking antibodies: development and application of a radioimmunoassay
8. Dose dependence of Hymenoptera venom immunotherapy
9. Venom-specific IgG and IgG antibodies as a measure of the degree of protection in insect sting sensitive patients
10. Correlation of IgG and IgE antibody levels to honeybee venom allergens with protection to sting challenge
11. Enzyme-linked immunosorbant assay (ELISA) for immunoglobulin G Antibodies against insect venoms
12. Regimens of Hymenoptera venom immunotherapy
13. Systemic reactions during maintenance immunotherapy with honey bee venom
14. Clinical relevance of the venom-specific immunoglobulin G antibody level during immunotherapy
15. Clinical and immunological studies of venom immunotherapy
16. Effects of passive antibody in bee venom anaphylaxis
17. Combination of passive and active immunization in honeybee venom immunotherapy
18. 125protein A from Staphylococcus aureus
19. Allergen specific IgG antibody measurements in the management of immediate hypersensitivity of Hymenoptera venoms
20. Human immune response to Hymenoptera venoms
21. Stinging insect allergy: natural history and modification with venom immunotherapy
22. Insect venom allergy
23. A controlled trial of immunotherapy in insect hypersensitivity
24. Insect allergy: the state of the art
25. Evolution of hymenoptera allergy
26. Assessment of venom-specific IgG antibody in patients treated for Hymenoptera hypersensitivity
27. The sting revisited
28. Stinging insect allergy
29. Treatment failures with whole body extract therapy of insect sting allergy
30. Natural history of allergy of Hymenoptera
31. The evaluation of the common diagnostic methods of hypersensitivity for bee and yellow jacket venom by means of an in-hospital insect sting
32. Evaluation of Hymenoptera sting sensitivity with deliberate insect sting challenges: inadequacy of present diagnostic methods
33. Is venom immunotherapy forever?
34. Natural history of insect sting anaphylaxis: evaluation of untreated and incompletely treated patients
35. Discontinuing venom immunotherapy (VIT): immunologic and clinical criteria
36. Prospective observations on patients who discontinue Hymenoptera venom immunotherapy
37. In-hospital sting challenge in insect venom-allergic patients after stopping venom immunotherapy
38. Honeybee venom allergy: results of a sting challenge 1 year after stopping venom immunotherapy in 85 patients